主题：Communication, Publications, and Nanomedicine: NBM
报告人：Lajos Balogh, PhD, Editor-in-Chief, Nanomedicine: Nanotechnology, Biology, and Medicine (Elsevier)
时间：11月20日上午10:00
地点：医学楼402栋1层会议室
欢迎广大师生踊跃参加！
放射医学与防护学院
放射医学及交叉学科研究院
2014年11月17日
摘要：
Nanomedicine is a rapidly emerging interdisciplinary area with many challenges, especially in the area of scientific communication. Effective verbal and written scientific communication is the basis of any advancement in technology, and it has even more importance for a field, which is being developed internationally.
Nowadays, we are generating knowledge faster than ever before. The information revolution and computers are changing the way scientific information is shared and evaluated. Science publishing is also undergoing dynamic changes from printing to online, and new business models, like open access and hybrid models are on the rise. The essential question is the same for authors and publishers: is it possible to determine the value of research (manuscript or publication) before and after making it public, and if the answer is yes, what are the best, objective methods to do that?
Getting published is crucial for academicians, researchers, and students. Hiring decisions are often made on the basis of publications therefore it is necessary to understand the mechanism, and find the best publication forum for maximum exposure.
In this talk, the speaker will explain how publishing works today, what is the difference between the fundamental business models, and will summarize major changes in science publications. He will describe the use and limits of citation based metrics and ranking, and explain current scientific methods to determine ranking of journals and magazines. You will learn how to select your target audience, and which tools can be used to evaluate publication activities of journals, individuals, institutions, and countries. Dr. Balogh will introduce the Nanomedicine NBM journal, its requirements, and procedures, and will compare it to leading nanomedicine journals. A guide how to get published in Nanomedicine NBM will also be presented with a question-and-answer opportunity.
Lajos Balogh, PhD简介：
Dr. Lajos (Lou) Balogh is the Editor-in-Chief of the journal Nanomedicine: Nanotechnology, Biology and Medicine (Elsevier) www.nanomedjournal.com, (2013 Impact Factor=5.98, 5-year IF=7.01).
Dr. Balogh is Adjunct Professor of Pharmaceutical Sciences at Northeastern University, Boston, MA, and Professor of the Chinese Academy of Sciences for Distinguished International Scientists. He authored or coauthored over 150 scientific publications (with over 5000 citations), six book chapters, delivered more than 200 invited presentations been and awarded 12 patents in various disciplines including chemistry, chemical technology, nanotechnology and nanomedicine.
Dr. Balogh received his Ph.D. from the Kossuth L. University in Hungary in Chemical Technology and later was invited to the University of Massachusetts Lowell as a Visiting Professor in 1991. He then worked at the Michigan Molecular Institute, Midland, MI as a senior scientist, and had faculty appointments (Department of Internal Medicine, Department of Biomedical Engineering and Macromolecular Science and Engineering) at the University of Michigan, Ann Arbor, MI. Before starting his own consulting business, he was the Co-Director of the NanoBiotechnology Center and Director of Nanotechnology Research in the Department of Radiation Medicine at the Roswell Park Cancer Institute, Buffalo, NY, and at the University at Buffalo, SUNY.
He is Owner and Chief Scientific Advisor (baloghl@prodigy.net) at the business AA Nanomedicine & Nanotechnology Consultants, North Andover, MA that provides scientific evaluation, feasibility studies, and concept assessments for nanomedicine related research applications, R&D projects, business plans and investments, as well as expert evaluation and technology due diligence for private companies, government agencies (NIH, NSF, DoD, USEPA, Chinese Academy of Sciences, etc.) and private investors in nanomedicine, nanobiotechnology, and nanotechnology since 2000.
Lou is member of the Nanobusiness Alliance, USA, and he serves on numerous USA, European, and International expert committees including the Steering Committee of the American National Standard Institute Nanotechnology Panel and the US Technical Advisory Committee to the International Standard Organization on Nanotechnology (TC-229).
Lou is one of the five Founders of the American Society for Nanomedicine (http://www.amsocnanomed.org).
Contact information:
Lajos P. Balogh, PhD
Editor-in-Chief,
Nanomedicine: Nanotechnology, Biology and Medicine (Elsevier)
http://www.nanomedjournal.com/
http://www.journals.elsevier.com/nanomedicine-nanotechnology-biology-and-medicine/
Phone: +1-617-629-0053
Mobile: +1-734-239-3342
(学部办公室)
